• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Aastrom


  • Please log in to reply
150 replies to this topic

#151 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 10 May 2012 - 09:19 AM

Aastrom Biosciences Announces First Patient Enrolled in REVIVE Phase 3 ...
Review seeker (press release) - May 10, 2012
By Globenewswire ANN ARBOR, Mich., May 9, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, ...

View the full article




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users